4/A//SEC Filing
RAY RUSSELL T 4/A
Accession 0001213900-22-042957
CIK 0001690080other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:16 PM ET
Size
8.0 KB
Accession
0001213900-22-042957
Insider Transaction Report
Form 4/AAmended
RAY RUSSELL T
Director
Transactions
- Award
Common Stock
2022-05-19$1.36/sh+10,570$14,375→ 15,298 total - Award
Non-Qualified Stock Option (right to buy)
2022-05-19+21,000→ 21,000 totalExercise: $1.36Exp: 2032-05-19→ Common Stock (21,000 underlying)
Footnotes (3)
- [F1]Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F2]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F3]The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001225960
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:16 PM ET
- Size
- 8.0 KB